• Home
  • MedDevices AI
  • Will Levita’s MARS Platform Redefine Solo Surgery with Autonomous Camera Integration?

Will Levita’s MARS Platform Redefine Solo Surgery with Autonomous Camera Integration?

Key Highlights:

  • Levita Magnetics’ MARS® platform used in first gallbladder removal surgery featuring an autonomous AI-guided camera.
  • Surgery performed without a camera assistant; AI tracks surgeon’s tools and adjusts view in real time.
  • Marks a crucial step toward surgical automation, with potential to improve precision, workflow efficiency and reduce OR staffing needs.

Autonomous Camera Enables Solo Laparoscopic Surgery

At Clínica Las Condes in Santiago, Chile, a gallbladder removal surgery was carried out by a surgeon without a human camera operator. Instead, an autonomous, AI-powered camera tracked the surgeon’s tools and continuously adjusted its angle, maintaining optimal visualization throughout the procedure. Ricardo Funke, chief of surgery, reported that the camera “was following me wherever I moved my hands … the whole process was excellent.”

MARS Platform: Technology & Capabilities

The operation leveraged Levita’s Magnetic-Assisted Robotic Surgery (MARS) system combined with magnetic surgical instruments and software intelligence. The autonomous camera system, using a high-definition 4K camera, automatically tracked and followed instruments, reducing dependency on a camera assistant and offering a more stable visual field.

Implications for Surgical Workflow & Safety

This advance promises multiple benefits: enhancing precision in minimally invasive surgeries, reducing delays and mistakes caused by human camera movement, potentially lowering staffing needs in operating rooms, and possibly improving patient outcomes by maintaining consistent visual focus.

Towards Surgical Automation: What’s Next?

While this case is significant, it’s one of the first in real‐patient applications. Developers and regulators will need more data on safety, reliability, variability in anatomy, and adverse situations (e.g. unexpected bleeding or instrument occlusion). A broader adoption would require regulatory approvals, clinical trials, and integration into surgical training.

Releated Posts

Could Cohere’s New Paris Office Accelerate AI Adoption Across Europe’s Healthcare and Biopharma Sector?

Key Insights: Expanding Footprint in Europe Cohere, a Canadian AI firm known for developing large language models and…

ByByAnuja SinghSep 16, 2025

Could Aiforia and Siemens Healthineers Transform Digital Pathology Across Europe With AI?

Key Insights: Strategic Partnership to Expand AI Pathology Aiforia Technologies Plc announced a major collaboration with Siemens Healthineers…

ByByAnuja SinghSep 16, 2025

Can Ant Group’s AQ AI Health App Redefine Access to Quality Care for 140 Million Users Across China?

Key Highlights Expanding AI Access in HealthcareSince its launch in June 2025, Ant Group’s AQ AI Health App…

ByByAnuja SinghSep 16, 2025

Will Apple’s FDA-Cleared Hypertension Detection Feature on the Apple Watch Redefine Global Digital Health for Millions?

Key Highlights FDA Approval Unlocks a New Era in Preventive CareApple’s hypertension detection feature, cleared by the U.S.…

ByByAnuja SinghSep 16, 2025
Scroll to Top